SPOTLIGHT -
Some speculate the pharmaceutical industry has virtually abandoned new drug development in neuroscience with a few exceptions. However, it should be noted that progress has been made.
Zuranolone for the Treatment of Adults With Major Depressive Disorder
Blue Light Blockers: A Behavior Therapy for Mania
Analyzing the Association Between Depressive Symptoms and Weight-Adjusted Waist Index
Blue Light, Depression, and Bipolar Disorder
The Week in Review: June 24-28
The Potential of Ketamine: Public Workshop and New Research Explores Uses